Skip to content
S2786Senate2013-2014 Session

Relates to the collection of prescription drug co-payments

Sponsor John A. DeFranciscoSD-50+4 co-sponsorsAffects Finance
Status
In Senate Committee
Rules
Impact
Pending
Passage
Pending

Bill progress

Step 2 of 7

In committee · Rules

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

Primary sponsor
John A. DeFrancisco

Senator · Senate District 50

Chair, Finance

History

  1. Committed to rules
  2. Advanced to third reading
  3. 2nd report cal.
  4. 1st report cal.1067
  5. Print number 2786a
  6. Amend and recommit to finance
  7. Reported and committed to finance
  8. Referred to health
  9. Recommitted to rules
  10. Ordered to third reading cal.1244
  11. Reported and committed to rules
  12. Reported and committed to finance
Show 1 earlier action
  1. Referred to health

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:S2786A

Title of bill

An act to amend the social services law, in relation to the collection of prescription drug co-payments

Purpose

To require patients to pay co-payments for prescription drugs at the point-of-sale under Medicaid.

Summary of provisions

Section 1- Amends section 367-a of the Social Services law to require the payment of prescription drug co-payments under Medicaid.

Section 2- Effective date.

Justification

Co-payments for prescription drugs in the State Medicaid program were implemented in New York State in 1995. It is the current policy that Medicaid and beneficiaries cannot be denied services if they refuse to pay their co-payments at the point-of-sale. As a result, pharmacies in the State of New York have experienced serious financial losses through the inability to collect the co-payments of $1 for generics and $3 for brand name drugs under Medicaid. Survey data has found that the statewide average of uncollectible co-payments is 50%, and the rate is even higher in New York City with some pharmacies experiencing uncollectible co-payments of 90%.

Unlike other providers which receive funding from bad debt and charity pools, pharmacies cannot write off their bad debt and do not receive state assistance to make up for these losses. Uncollectible co-payments come directly out of the pockets of community pharmacies. Pharmacies have also recently experienced significant reductions in reimbursement under Medicaid and are currently paid one of the lowest rates in the country. This hardship is exacerbated by the losses incurred through uncollectible co-payments in the program. This situation is inequitable and also jeopardizes access to pharmacy services for all New Yorkers.

Recently, the pharmacy benefit under Medicaid was changed and will now be administered by private managed care plans for the majority of beneficiaries. However, the co-payments remain the same as does the policy regarding pharmacy collection. This means that pharmacies will continue to lose on average 50% of co-payments for the prescription drugs filled for approximately four million New Yorkers.

This inequity would be addressed through this legislation by requiring Medicaid beneficiaries to pay their co-payments to pharmacies at the point-of-sale when filling their prescriptions.

Legislative history

S.4749A/A.7727 of 2011-2012

Fiscal implications

None

Effective date

This act shall take effect one hundred and eighty days after it shall become law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.